Compare CYTK & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | IBP |
|---|---|---|
| Founded | 1997 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.3B |
| IPO Year | 2004 | 2014 |
| Metric | CYTK | IBP |
|---|---|---|
| Price | $60.52 | $287.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 8 |
| Target Price | $87.56 | ★ $276.00 |
| AVG Volume (30 Days) | ★ 1.7M | 334.6K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | N/A | ★ 6.70 |
| EPS | N/A | ★ 9.71 |
| Revenue | $13,368,000.00 | ★ $2,970,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $302.66 | $4.53 |
| P/E Ratio | ★ N/A | $29.66 |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $29.31 | $150.83 |
| 52 Week High | $70.98 | $349.00 |
| Indicator | CYTK | IBP |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 40.90 |
| Support Level | $59.25 | $254.83 |
| Resistance Level | $65.93 | $293.53 |
| Average True Range (ATR) | 2.76 | 14.99 |
| MACD | -0.35 | -5.24 |
| Stochastic Oscillator | 18.21 | 26.35 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.